INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2016

Cancer cachexia affects 50% to 80% of cancer patients, causing skeletal muscle loss and contributing to at least 20% of cancer deaths.

Cancer patients remain among the most malnourished patient groups, with cancer cachexia (CC) affecting 50-80% of cancer patients and accounting for at least 20% of deaths. The syndrome drives skeletal muscle loss (sarcopenia) through pro-inflammatory cytokines and tumor-derived factors, occurring even with adequate food intake. Sarcopenia is present in 20-70% of patients depending on tumor type, impairing physical function, treatment tolerance, and survival. Identifying muscle loss is complicated because 40-60% of cancer patients are overweight or obese, even with metastatic disease.

Study type
Narrative review
Who was studied
Cancer patients
What was measured
Prevalence and clinical impacts of cancer cachexia, malnutrition, and sarcopenia

THE PAPER

Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later.

Ryan AM, Power DG, Daly L, Cushen SJ, Ní Bhuachalla Ē, Prado CM. Proc Nutr Soc, 2016.

PubMed 26786393 ↗DOI 10.1017/s002966511500419x ↗

CancerNutrients & adequacyWeight & appetite

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.